NY-AMERICAN-EXPRESS
12.3.2024 14:01:28 CET | Business Wire | Press release
American Express Travel® released its 2024 Global Travel Trends Report1 today, highlighting the inspiration and trends driving global travel bookings this year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312265470/en/
American Express Reveals 2024 Top Travel Trends. (Photo: Business Wire)
The report, based on survey data from travelers in the United States, Australia, Canada, India, Japan, Mexico, and the United Kingdom, found that 84% of respondents plan to spend more or the same amount of money on travel in 2024 compared to last year. Additionally, 77% of respondents care more about having the right travel experience than about the cost of the trip.
The four trends driving booking decisions are:
- For the Love of the Game: Sports fans are planning trips around athletic events, whether it involves a favorite sport, a beloved team, or an international multi-sport competition
- Planning Big: Major, expedition-style adventures, like a trip to the Galapagos Islands or trekking with the gorillas, deliver the transformative experiences that travelers are looking for
- Going Solo: Travelers are takings trips alone, embracing the ease of planning and ability to tailor itineraries that are a perfect fit
- On a Whim: With so much of life being structured and scheduled these days, people are seeking flexibility in their travel plans and leaving room for spontaneity
“Travelers are focused on creating the right itineraries and building memories, whether that means booking a trip to see a favorite sports team compete or taking a once-in-a-lifetime expedition cruise,” says Audrey Hendley, President of American Express Travel. “Our Global Travel Trends Report sheds light on what is driving global travel bookings and provides inspiration for where to go next. Our American Express Travel Consultants can help, no matter what type of trip you want to take.”
Top insights from American Express Travel’s 2024 Global Travel Trends Report include:
-
A desire to see sporting events live and to watch favorite teams and beloved players in person are driving where travelers are going and what they are doing when they get there.
- 67% of Millennial and Gen Z respondents2 (compared to 58% of all respondents) are interested in traveling for sporting events in 2024
- 58% of respondents who are traveling for sports in 2024 will do so for soccer, basketball or Formula 1 racing
- New York, Miami and Paris are the top destinations respondents are planning to travel to for sporting events this summer
-
Transformative, once-in-a-lifetime trips, like visiting the Galapagos Islands and hiking in Antarctica, are at the top of many travelers’ wish lists, and younger travelers want an expert to help them plan.
- 65% of respondents are more interested in taking a major trip in 2024 than in previous years
- 72% of respondents would rather save money for a major trip than spend it on going out with friends; and more than half of respondents plan on saving between 6 months to 2 years for a major trip
- 58% of Millennial and Gen Z respondents want a travel agent or trusted advisor to help them book a major trip this year
- 55% of respondents planning a major trip would consider visiting multiple countries in a region
-
The ease of planning and ability to make the perfect, personalized itinerary is driving people to plan trips alone, especially younger travelers.
- 76% of Millennials and Gen Z respondents (compared to 69% of all respondents) say they are planning on taking a solo trip 2024
- 74% of male respondents and 63% of female respondents say they are planning on taking a solo trip in 2024
- 66% of respondents planning on traveling solo are planning a trip tailored to treat themselves
- 60% of respondents planning on traveling solo this year intend to take two or more solo trips
-
Travelers are leaning into flexible itineraries, allowing them the freedom to be spontaneous and experience the local culture when they travel.
- 78% of respondents say that spontaneous trips appeal to them
- 77% of Millennials and Gen Z have booked a last-minute trip before, compared to 65% of Gen X3 and 52% of Baby Boomers4
- 68% of respondents agree that they like to leave unplanned time in their trip to experience local culture/activities
- 57% of respondents prefer booking a last-minute getaway to a nearby destination rather than somewhere far away
As the demand for travel continues into 2024, American Express provides eligible Card Members with exceptional travel access and experiences, including 1,400+ airport lounges through its Global Lounge Collection®; expert Travel Consultants who can build dream itineraries for everything from major trips like an expedition cruise or safari, to quick weekend getaways; restaurant reservations through Resy and curated where-to-eat guides at Resy.com/Travel; benefits across global sporting experiences and venues; benefits at over 2,000 hand-picked hotels around the world via Fine Hotels + Resorts® and The Hotel Collection; more than 1,000 premium vacation rental properties via Select Homes + RetreatsTM, and more.
The full American Express Travel 2024 Global Travel Trends Report can be viewed here.
ABOUT AMERICAN EXPRESS
American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, threads.net/@americanexpress, tiktok.com/@americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress.
Key links to products, services and corporate sustainability information: personal cards, business cards and services, travel services, gift cards, prepaid cards, merchant services, Accertify, Business Blueprint, Resy, corporate card, business travel, diversity and inclusion, corporate sustainability and Environmental, Social, and Governance reports.
1Survey Methodology: This poll was conducted between January 31 – February 8, 2024 among a sample of 2,005 US Adults, 1,007 Australia Adults, 1,002 Canada, 1,002 UK Adults, 1,002 Japan Adults, 1,006 Mexico Adults and 1,005 India Adults who have at least a $50k+ income equivalent and typically travel at least once a year. The interviews were conducted online. Results from the full survey have a margin of error of plus or minus 2-4 percentage points. Some geographies may be weighted with fewer variables depending on local census data availability.
2Millennials and Gen Z are defined as respondents as being born between 1981 - 2012.
3GenX are defined as respondents as being born between 1965 - 1980.
4Baby Boomers are defined as respondents as being born between 1946 - 1964.
Seller of Travel
American Express Travel Related Services Company, Inc. is acting solely as a sales agent for travel suppliers and is not responsible for the actions or inactions of such suppliers. Certain suppliers pay us commission and other incentives for reaching sales targets or other goals and may provide incentives to our Travel Consultants. For more information visit www.americanexpress.com/travelterms.
California CST#1022318; Washington UBI#600-469-694
Source: American Express Company
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312265470/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
